TP53 mutations predicts worse prognosis in EGFR-mutated NSCLC patients receiving TKIs in first- or further line of treatment-MedSci.cn

TP53 mutations predicts worse prognosis in EGFR-mutated NSCLC patients receiving TKIs in first- or further line of treatment

Canale, M; De Luigi, N; Petracci, E; Delmonte, A; Ludovini, V; Dubini, A; Baglivo, S; Minenza, E; Chiadini, E; Landi, L; Papi, M; Bronte, G; Crino, L; Ulivi, P

ANNALS OF ONCOLOGY, 2019; 30 ():

科室
- - 订阅+
  - 更多科室
工具
服务